Literature DB >> 20416330

Central amylin acts as an adiposity signal to control body weight and energy expenditure.

Peter Y Wielinga1, Christian Löwenstein, Sabine Muff, Manuela Munz, Stephen C Woods, Thomas A Lutz.   

Abstract

The pancreatic B-cell hormone amylin has been proposed to be both a satiation signal and an adiposity signal. The effects of peripheral amylin on energy balance are well investigated, but the effects of central amylin are less clear. We determined the effects of low doses of amylin administered into the 3rd cerebral ventricle (i3vt) on food intake, body weight and other indices of energy balance. Amylin (2 pmol/h) significantly lowered body weight compared to saline after 2 weeks of infusion, independent of whether prior body weight was decreased by fasting, increased by voluntary overfeeding or unmanipulated. A bolus injection of amylin (10 pmol, i3vt) increased energy expenditure and body temperature, whereas chronic i3vt amylin infusion had no effect on energy expenditure above that of control rats even though body temperature was increased. Chronic amylin also reduced RQ, implying a preferential oxidation of fat. Overall, the data provide new evidence that amylin is an adiposity signal that acts within the brain, and informing the brain about the status of peripheral energy stores. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416330      PMCID: PMC2900396          DOI: 10.1016/j.physbeh.2010.04.012

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  41 in total

Review 1.  UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency.

Authors:  J Nedergaard; V Golozoubova; A Matthias; A Asadi; A Jacobsson; B Cannon
Journal:  Biochim Biophys Acta       Date:  2001-03-01

2.  Amylin: a novel action in the brain to reduce body weight.

Authors:  P A Rushing; M M Hagan; R J Seeley; T A Lutz; S C Woods
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

3.  The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats.

Authors:  T A Lutz; A Mollet; P A Rushing; T Riediger; E Scharrer
Journal:  Int J Obes Relat Metab Disord       Date:  2001-07

4.  Validation of computed tomographic estimates of intra-abdominal and subcutaneous adipose tissue in rats and mice.

Authors:  Jacquelien J G Hillebrand; Wolfgang Langhans; Nori Geary
Journal:  Obesity (Silver Spring)       Date:  2009-10-22       Impact factor: 5.002

Review 5.  Central amylin signaling and the regulation of energy homeostasis.

Authors:  Paul A Rushing
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

6.  Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity.

Authors:  Barry E Levin; Ambrose A Dunn-Meynell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-01       Impact factor: 3.619

7.  Inhibition of central amylin signaling increases food intake and body adiposity in rats.

Authors:  P A Rushing; M M Hagan; R J Seeley; T A Lutz; D A D'Alessio; E L Air; S C Woods
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

8.  Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.

Authors:  Andrea Mollet; Simone Gilg; Thomas Riediger; Thomas A Lutz
Journal:  Physiol Behav       Date:  2004-03

9.  Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.

Authors:  Priscilla Hollander; David G Maggs; James A Ruggles; Mark Fineman; Larry Shen; Orville G Kolterman; Christian Weyer
Journal:  Obes Res       Date:  2004-04

10.  Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences.

Authors:  Paul A Rushing; Randy J Seeley; Ellen L Air; Thomas A Lutz; Stephen C Woods
Journal:  Peptides       Date:  2002-05       Impact factor: 3.750

View more
  28 in total

Review 1.  Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?

Authors:  Nina Carlier; Victoria S Marshe; Jana Cmorejova; Caroline Davis; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

2.  Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.

Authors:  R J Bailey; C S Walker; A H Ferner; K M Loomes; G Prijic; A Halim; L Whiting; A R J Phillips; D L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

4.  A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.

Authors:  Sofie Gydesen; Sara Toftegaard Hjuler; Zenia Freving; Kim Vietz Andreassen; Nina Sonne; Lars I Hellgren; Morten Asser Karsdal; Kim Henriksen
Journal:  Br J Pharmacol       Date:  2017-02-15       Impact factor: 8.739

Review 5.  Control of energy homeostasis by amylin.

Authors:  Thomas A Lutz
Journal:  Cell Mol Life Sci       Date:  2011-12-23       Impact factor: 9.261

Review 6.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

Review 7.  Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.

Authors:  T A Lutz
Journal:  Int J Obes Suppl       Date:  2016-11-16

8.  Human islet amyloid polypeptide at the air-aqueous interface: a Langmuir monolayer approach.

Authors:  Shanghao Li; Miodrag Micic; Jhony Orbulescu; Jeffrey D Whyte; Roger M Leblanc
Journal:  J R Soc Interface       Date:  2012-07-11       Impact factor: 4.118

Review 9.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

10.  Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.

Authors:  Kathrin Abegg; Marc Schiesser; Thomas A Lutz; Marco Bueter
Journal:  Physiol Behav       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.